FAQ

Pancreatic Endocrine Carcinoma

Known as: Islet Cell Carcinoma, Malignant Pancreatic Endocrine Tumor, High Grade Pancreatic Neuroendocrine Carcinoma 
An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas. The mitotic count is… (More)

Topic mentions per year

Topic mentions per year

1942-2017
05101519422016

Related topics

Related topics

30 relations
Blood supply aspectsCDISC SEND Tumor Findings Results TerminologyClinical Data Interchange Standards Consortium TerminologyDacarbazine
(More)

Broader (5)

CarcinomaIslet Cell TumorMalignant neoplasm of endocrine pancreasMalignant neoplasm of pancreas
(More)

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Pancreatic Endocrine Carcinoma
cancer cell
Carcinoma
radiotherapeutic
Pancreas
Gastrointestinal system

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer.
PURPOSE Pertuzumab, a recombinant humanized monoclonal antibody (2C4), binds to extracellular domain II of the HER-2 receptor and… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
BACKGROUND The objective of this study was to determine the prognostic variables that influence response and survival in patients… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Differences in survival by histologic type of pancreatic cancer.
OBJECTIVE Although pancreatic cancer has an extremely high case fatality rate, little is known about differences in mortality by… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.
PURPOSE The role of systemic chemotherapy in the management of pancreatic endocrine carcinoma (islet cell carcinoma; PEC) is an… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
The Eph family of receptor tyrosine kinases and their ligands, known as ephrins, play a crucial role in vascular development… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282.
BACKGROUND A phase II study of dacarbazine (DTIC), was conducted to determine the response rate, duration of response, toxicity… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases.
BACKGROUND Neuroendocrine tumor metastases to the liver are generally slow growing, but patients suffer from hormone… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The management of patients with advanced carcinoid tumors and islet cell carcinomas.
OBJECTIVE To determine the effectiveness of hepatic artery occlusion alone and with sequenced chemotherapy for patients with… (More)
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Islet cell carcinomas of the pancreas: a twenty-year experience.
Unlike its lethal exocrine counterpart, islet cell carcinoma of the pancreas is an indolent neuroendocrine neoplasm. The majority… (More)
Is this relevant?
Highly Cited
1973
Highly Cited
1973
Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients.
 
Is this relevant?